Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Diseases, Interstitial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06325696
What this trial is testing

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisLung Diseases, Interstitial
National Institute of Environmental Health Sciences (NIEHS) 37
Testing effectiveness (Phase 2)Ended earlyNCT02631603
What this trial is testing

Stop Exogenous Allergic Alveolitis (EAA) in Childhood

Who this might be right for
Hypersensitivity PneumonitisExogenous Allergic Alveolitis
Matthias Griese 4
Not applicableStudy completedNCT03222648
What this trial is testing

Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis

Who this might be right for
BreathlessnessQuality of LifeIdiopathic Pulmonary Fibrosis
University Hospital Southampton NHS Foundation Trust 17
Not applicableStudy completedNCT02645968
What this trial is testing

Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING

Who this might be right for
Interstitial Lung Disease (ILD)
Heidelberg University 600
Not applicableStudy completedNCT03211507
What this trial is testing

Idiopathic Pulmonary Fibrosis Job Exposures Study

Who this might be right for
IPFIdiopathic Pulmonary Fibrosis
Imperial College London 960
Early research (Phase 1)Study completedNCT06569381
What this trial is testing

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

Who this might be right for
Idiopathic Pulmonary Fibrosis
Overseas Pharmaceuticals, Ltd. 18
Not applicableApproved For MarketingNCT02141087
What this trial is testing

Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc.
Not applicableUnknownNCT05635032
What this trial is testing

Fibrosing ILD Biomarkers That Rule Acceleration

Who this might be right for
Pulmonary FibrosisSarcoidosis
Universidade do Porto 150
Testing effectiveness (Phase 2)Ended earlyNCT02452463
What this trial is testing

Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaRadiation-Induced PneumonitisStage II Lung Non-Small Cell Cancer AJCC v7+6 more
Roswell Park Cancer Institute 8
Early research (Phase 1)Study completedNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Not applicableStudy completedNCT06563011
What this trial is testing

The Assessment of Nutritional Status of Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
İrem Çağla Özel 31
Not applicableUnknownNCT05866198
What this trial is testing

Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation

Who this might be right for
Lung Diseases, Interstitial
University of South Florida 70
Testing effectiveness (Phase 2)Looking for participantsNCT06053164
What this trial is testing

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
University of Alberta 60
Not applicableUnknownNCT05631132
What this trial is testing

May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?

Who this might be right for
Chronic Obstructive Pulmonary DiseaseInterstitial Lung Disease
Medical University of Silesia 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Looking for participantsNCT07201922
What this trial is testing

Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Who this might be right for
Familial Pulmonary FibrosisInterstitial Lung AbnormalitiesInterstitial Lung Diseases
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Temporarily pausedNCT05387239
What this trial is testing

Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19

Who this might be right for
Pulmonary FibrosisCOVID-19 Respiratory Infection
Vitti Labs, LLC 20
Testing effectiveness (Phase 2)Study completedNCT00063869
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Wyeth is now a wholly owned subsidiary of Pfizer 88
Not applicableLooking for participantsNCT07300696
What this trial is testing

Functional MRI for Monitoring Progression and Assessing Trends in ILD

Who this might be right for
Interstitial Lung Diseases (ILD)
University Hospital Heidelberg 200
Not applicableLooking for participantsNCT07236541
What this trial is testing

Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study

Who this might be right for
Lung Fibrosis
Ming Zhong 20
Next Page